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The ct- and fl-subunits of fl-hexosaminidase (fl-N-acetylhexosaminidase, EC 3.2.1.52) are synthesized in the rough endo- 
plasmic reticulum as prepropolypeptides. After the loss of the signal peptide and formation of enzymatically active 
dimers, the pro-isoenzymes are transported through the Golgi and into the lysosome for proteolytic and glycolytic pro- 
cessing to their stable mature forms. Maturation includes the hydrolysis, and previously presumed loss, of small N-termi- 
nal peptides from each propolypeptide. A recent report characterizing the processing of the fl-prepropolypeptide n fl-hex- 
osaminidase from a human fibroblast cell line [(1989) J. Biol. Chem. 264, 3380-3384] reported that the small pro-fl peptide 
was retained through a disulfide bond in the mature subunit, and that it was glycosylated. We have confirmed this result 
in normal human tissue. However, we report a different N-terminal for the mature pro-fl peptide. Furthermore, we have 
found that the pro-or peptide is similarly retained in the mature ct-subunit through its single cysteine residue and that 
each pro-peptide undergoes C-terminal processing. 
Lysosome; Structure; Biosynthesis; Posttranslational processing 
1. INTRODUCTION 
As typical glycoproteins, the components of/3- 
hexosaminidase (Hex) are synthesized in the rough 
endoplasmic reticulum (RER) as prepropolypep- 
tides. The presequence, the signal peptide, is 
cleaved shortly after entry into the RER resulting 
in the propolypeptides. After passage through the 
Golgi which must include the phosphorylation f 
one or more of the oligosaccharides forbinding to 
the phosphomannosyl receptor (reviewed in [1]), 
the stable mature subunits are produced through 
proteolytic and glycolytic processing in the 
lysosome. 
Utilizing purified isozymes from human placen- 
ta in our studies [2-6] or in vivo labeling of Hex 
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in human fibroblasts by others [7-9], the details of 
the biosynthesis and posttranslational processing 
of the Hex subunits have largely been established. 
The single proteolytic event hat occurs outside of 
the lysosome, signal peptide cleavage, results in N- 
termini at residues 23 and 43 for the pro-ce and pro- 
/5' polypeptides, respectively [5,8] (fig.l). Specific 
internal cleavages and trimming of the proteins in 
the lysosome generate a 53 kDa a-chain and two/3- 
polypeptides which we have called/3b (basic p/) and 
/3a (acidic p/) of similar molecular mass 
(26-30 kDa) [3,4] (fig.l). In the case of the pro-or 
chain, cleavage at the N-terminus results in an in- 
termediate species beginning at residue 87 (Arg) 
[8]. Further trimming to residue 89 (Thr) or 90 
(Leu) yields the N-terminus of the mature a-chain 
[4,8]. The N-termini of the mature/3-peptides were 
mapped to residues 122 in the/3b chain and 315 or 
316 in the/3a chain of Hex A or B, respectively 
[4,9]. This cleavage between the/3b and/3a chains 
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involves the loss of  four (in Hex A) or three (Hex 
B) residues between them [4]. 
Unt i l  recently, it was assumed that the residues 
between the signal pept ide cleavage points and the 
mature  N-termini  of  the u (~rp, residues 23-87)  and 
~b chains 63p, residues 43-122) were lost. 
However ,  the deduced amino acid sequences of  
both  o f  these peptides contain a single cysteine 
residue [10]. Furthermore,  #tp contains a possible 
site for Asn- l inked glycosylat ion [6]. In a recent 
report ,  Quon et al. [9] found that the 13p peptide 
(referred to as 'c '  in the reference) was retained 
through a disulf ide bond in the mature 13-subunit 
f rom a human f ibroblast  cell line. These authors 
determined that ~p was glycosylated and had an N- 
terminus init ial ly at residue 45 (Ala) that was fur- 
ther t r immed to residue 48 (Val) (fig. 1). They were 
unable to f ind a corresponding Up sequence. In this 
report ,  we have extended their f indings to the 
demonstrat ion  of the presence of  both Up and #'p in 
the mature Hex isozymes f rom human placenta 
and def ined their N- and C-termini.  
2. MATERIALS  AND METHODS 
2.1. Separation of the polypeptide components of mature 
Hex A and B 
Samples containing =3 mg of purified placental Hex A and 
0.5 mg of Hex B [2] were precipitated with 4 vol. of acetone, 
dried and dissolved in 250/A of a buffer containing 0.625 M 
Tris/HCl, pH 6.8, and 3070 SDS (Laemmli sample buffer [10]). 
Each sample was incubated at 60°C for 20 min, centrifuged and 
injected into high performance liquid chromatography sieve 
columns (two linked TSK-4000 molecular sieve columns, 
7.5 mm × 300 mm; HPLC-Mr) [11], eluted at 0.5 ml/min with 
a 0.1 M phosphate buffer, pH 6.0, containing 0.1070 SDS. Pro- 
tein was detected by constantly monitoring the column effluent 
at A2so. The peaks (=2 ml), containing the nonreduced ~- 
subunit from Hex B or the nonreduced o~- and #'-subunits from 
Hex A, were collected by hand. Three portions of each peak 
(=80/,g/portion) were retained for analysis by SDS-PAGE 
(below). The remaining samples from each isoenzyme were 
freeze-dried and dissolved in 250/~l of 50 mM DTT, incubated 
at 60°C for 20 rain, and reapplied to the HPLC-Mr columns. 
The small protein peak eluting at 45 min, between the peak con- 
taining the~a ndflb chains (41.5 min) and the Vtotm of the col- 
umns (60 min), corresponding to a molecular mass of 
< 14.5 kDa was collected from each isozyme. The SDS was 
removed from the sample by ion-pair extraction [4]. The amino 
acid composition of the remaining Hex B component and 10°70 
of the sample from Hex A was determined using the PICOTAG 
method [12]. The partial N-terminal sequence (the residues in 
ten sequenator 'turns') of the remaining sample from Hex A 
was determined as previously described [13]. 
2.2. Polyacrylamide gel electrophoresis 
PAGE-SDS was carried out on a Biorad minigel apparatus 
using the method of Laemmli [10] with an 18070 running gel. 
Two 'analytical' nonreduced samples from the HPLC-Mr 
(---80/~g) were dialyzed against sample buffer diluted 1:4. The 
samples were freeze-dried and redissolved in 25/Ll of water 
(nonreduced) or water containing 50 mM DTT (reduced), in- 
cubated at 60°C for 20 min, mixed with 5 izlof tracking dye in 
75°70 glycerol, and applied to the SDS-slab gel. Proteins were 
stained with Coomassie blue or silver reagent [14]. 
The third Hex A derived analytical aliquot from the HPLC- 
Mr was treated with 2 U of glycopeptidase F and the third Hex 
B-derived sample was treated with 0.01 U of endoglycosidase H 
(Boehringer-Mannheim) as previously described [4,15]. The 
samples were then analyzed by SDS-PAGE. 
3. RESULTS AND DISCUSSION 
The separat ion of  nonreduced and reduced 
samples of  puri f ied human placental  Hex A and B 
by HPLC-Mr  eluted with 0.1% SDS, resulted in 
the detect ion of  a previously uncharacter ized 
minor  protein peak found exclusively in each of  
the reduced samples. This peak eluted in the ex- 
treme lower Mr range of  the columns (fig.2). We 
had previously separated r uced and alkylated u-  
and f l -chains by HPLC-Mr  using 5 M guanidine- 
HC1 and isolated the chains by ethanol precipita- 
t ion [4,6]. It appears that these small peptides were 
either not precipitated by this procedure or that 
they eluted with the large Vtotal peak and were not 
col lected. 
Part ia l  N-terminal  sequence analysis of  the pro- 
tein contained in the new peaks f rom reduced 
samples of  placental  Hex A,  conf i rmed the 
presence of  the tip sequence reported by Quon et al. 
[9]. However,  the placental  peptide sequence 
began at residue 50, A la  ( f ig. l ) ,  instead of  45 
and/or  48 as reported for the f ibroblast peptide. 
Surprisingly, the part ia l  N-terminal  sequence 
revealed a second pept ide through the presence of  
a second residue in each sequenator turn. This ad- 
dit ional  pept ide sequence corresponds exactly to 
residues 23 (Leu) -33 (Thr) in the deduced u-  
sequence and is designated crp (f ig. l ) .  Thus both 
the up and the #'p sequences are retained in the 
mature  Hex A through disulf ide bonds,  and while 
the tip peptide undergoes the loss of  7 residues 
f rom its initial N-terminus at the signal peptide 
cleavage site, the N-terminus of  the up chain is not 
further processed. (Since, unlike the mature /5'- 
subunit ,  there are no 'a '  and 'b '  polypept ides in the 
u-subunit ,  we have chosen a nomenclature utiliz- 
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Fig. 1. Deduced primary structures of the N-terminal section of the prepro-a and -fl polypeptide chains of Hex [11]. The site of signal 
peptide cleavage is marked by a vertical arrow [5,8]. Arrowheads represent sites of hydrolysis giving rise to stable intermediates [8,9]. 
Shadowed sequences are the deduced a v and fl~ peptides. While the partial N-terminal sequences (dotted underline) were unequivocally 
identified in this report, the C-termini were calculated from amino acid composition data and could vary by +_ 2 residues. The N-linked 
glycosylation site in the ~'v peptide and the Cys residues in both peptides are underlined. Homologies between the a-  and Z?-sequences 
are indicated by asterisks. Amino acids between residues 42-50 and 107-122 in the ~'-sequence, and residues 74-89 in the a are not 
present in the mature isozymes, presumably due to N-terminal and/or  C-terminai processing (note the lack of  sequence homology in 
these areas). Residue 90 (Leu) rather than 89 (Thr) was found to be the exclusive mature N-terminus in fibroblasts [8], while it and 
residue 89 were found in equal proportions as the N-terminal residue in mature a-chains from human placental Hex A [4]. 
ing the subscript 'p' for both the a and ~' pro- 
peptides, rather than the 'c' nomenclature used by 
Quon et al. [9]. Thus, the detailed structure of 
mature Hex A is [ ( te~' ) (~a) ]  and that of Hex B 
is 2(6'~'~'a). For simplicity we suggest the general 
use of the pro-isozymes structures, i.e. cet and t t ,  
respectively.) 
The amino acid analysis of purified tp from Hex 
B and the ap-tp mixture from Hex A (not shown), 
indicated that both peptides undergo C-terminal 
processing. With the knowledge that residues 50 
and 122 are the sites of the N-termini of the mature 
tp and tb chains, respectively, it was possible to 
deduce the most likely C-terminus of the tp chain 
from the amino acid composition of the purified 
peptide in comparison to the total deduced se- 
quence of this region of the protein deduced from 
the cDNA. This assigned the C-terminus of the tp 
chain of Hex B to residue 107 (Gly, fig.2). 
Further, the C-terminus of the a,p component of 
the a~v-tv HPLC pool from Hex A was determined 
in relation to the His content of the sample. Since 
there is no His residue in the deduced ~r v sequence, 
the amount of His in the mixed sample was directly 
proportional to the tp component. After subtrac- 
tion of the calculated tp fraction from the amino 
acid composition of the pool, the ratios of the cep 
amino acids were compared with the deduced cep 
sequence. The peptide that best fit both sets of 
data, given an N-terminus at residue 23, would end 
at residue 74 (Gly, fig.2), aligning exactly with the 
putative C-terminus of tp. Thus, c~p contains 52 
amino acids while the tp is composed of 58 
residues. 
Fig.3 A and B shows the SDS-PAGE pattern of 
reduced and nonreduced samples of Hex A (silver 
stained) and Hex B (Coomassie blue stained), 
respectively. Like the tv peptide from fibroblasts 
[9] the placental peptide, from samples reduced 
prior to application, runs as a doublet (fig.3, tip). 
However, it is converted to a 'fuzzy' singlet on 
treatment with either glycopeptidase F (fig.3 A, A- 
R + Glyco F) or endoglycosidase H (not shown). 
This indicates that the single putative glycosylation 
site in the tv chain contains a high mannose-type 
oligosaccharide. 
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Fig.2. HPLC-Mr separation of reduced samples of Hex A 
(panel A) and Hex B (panel B). The identity of each protein 
(A2go) peak is indicated. A standard Mr curve is shown as an 
inset to panel B. 
It is evident from fig.3 why this peptide has been 
previously overlooked. The Bv bands are barely 
visible in contrast to extremely pronounced mature 
Ha and Bb bands even when the mini-slab gel is 
overloaded (80/~g/lane). Even at this level of 
detection, a band corresponding to crp in the Hex 
A sample cannot be seen (fig.3, panel A). Since 
this peptide was not detected in the gels produced 
by Quon et al. [9] who were visualizing labeled 
protein, it is likely that the ap peptide cannot be 
fixed within the gel. 
It is not known whether the oligosaccharide on 
the Bp peptide from fibroblasts or placenta is 
i ilii! !ii!ili!ilili~i 
) ,  
Fig.3. Molecular mass standards from the Pharmacia 'low 
molecular mass standard kit' (Std.) are shown at the side of 
each gel. (Panel A) SDS-PAGE separation of nonreduced Hex 
A (A-R), reduced Hex A (A-NR), and reduced Hex A treated 
with glycopeptidase F (A-R + Glyco F), =80/~g of 
protein/lane, visualized with silver reagent. The 'fuzzy' 
deglycosylated Bp hand is indicated. (Panel B) SDS-PAGE of 
nonreduced Hex B (B-NR) and reduced Hex B (B-R), =80 ,~g of 
protein/lane, visualized with Coomassie blue. The glycosylated 
tip doublet (consistent with that found in fihroblasts [9]) is 
indicated. 
phosphorylated. As such, the possibility of a 
physiological role for tip in the intracellular 
transport of the B-subunit cannot be entirely ruled 
out. Similarly, any biological function related to 
either of the protein domains in ap or Bp in the 
native Hex isoenzymes remains to be determined. 
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